US Stock MarketDetailed Quotes

ONTXW Onconova Therapeutics, Inc.

Watchlist

0.000
0.0000.00%

Close Jul 5 09:30 ET

0Market Cap0.00P/E (TTM)

Onconova Therapeutics, Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

(Q2)Jun 30, 2019

Assets

Current assets

Cash, cash equivalents and short term investments

54.68%48.01M

-16.29%19.03M

401.93%24.2M

362.90%27.23M

198.54%31.04M

33.92%22.73M

-78.46%4.82M

-80.09%5.88M

-Cash and cash equivalents

54.68%48.01M

-16.29%19.03M

401.93%24.2M

362.90%27.23M

198.54%31.04M

33.92%22.73M

-78.46%4.82M

-80.09%5.88M

Receivables

-15.56%38K

-62.24%37K

100.00%46K

-97.61%41K

28.57%45K

180.00%98K

-4.17%23K

2,280.56%1.71M

-Accounts receivable

-15.56%38K

-62.24%37K

100.00%46K

--41K

28.57%45K

180.00%98K

-4.17%23K

----

-Related party accounts receivable

----

--1.68M

-Other receivables

----

--35K

Prepaid assets

-31.24%394K

6.27%542K

-35.48%560K

-45.01%408K

-12.79%573K

-26.30%510K

46.37%868K

60.61%742K

Other current assets

-4.05%213K

28.57%180K

121.35%197K

242.86%312K

117.65%222K

105.88%140K

-13.59%89K

9.64%91K

Total current assets

52.62%48.65M

-15.72%19.78M

330.98%25M

232.06%27.99M

184.86%31.88M

32.14%23.47M

-74.89%5.8M

-72.05%8.43M

Non current assets

Net PPE

4.26%49K

4.00%52K

3.70%56K

5,900.00%60K

4,600.00%47K

455.56%50K

170.00%54K

-97.06%1K

-Gross PPE

-96.93%70K

0.61%2.3M

3.14%2.3M

2.47%2.28M

2.51%2.28M

0.00%2.23M

-Accumulated depreciation

99.06%-21K

99.19%-18K

-0.54%-2.24M

-0.49%-2.24M

-0.40%-2.24M

-0.63%-2.23M

-1.00%-2.23M

-1.50%-2.23M

Related parties assets

----

--1.68M

Other non current assets

0.00%150K

0.67%150K

1,150.00%150K

Total non current assets

1.02%199K

1.00%202K

0.98%206K

39.07%210K

30.46%197K

26.58%200K

537.50%204K

228.26%151K

Total assets

52.31%48.85M

-15.58%19.99M

319.77%25.21M

228.66%28.2M

182.81%32.07M

32.09%23.67M

-74.04%6.01M

-71.59%8.58M

Liabilities

Current liabilities

Payables

-4.66%3.99M

13.16%4.83M

26.55%5.73M

8.38%5.15M

-3.48%4.18M

5.74%4.27M

6.10%4.52M

-20.15%4.75M

-accounts payable

-4.66%3.99M

13.16%4.83M

26.55%5.73M

8.38%5.15M

-3.48%4.18M

5.74%4.27M

6.10%4.52M

-20.15%4.75M

Current accrued expenses

2.23%2.02M

20.59%2.72M

-8.61%2.11M

6.19%2.4M

-9.82%1.98M

-10.04%2.26M

0.78%2.31M

-0.57%2.26M

Current deferred liabilities

0.00%226K

-50.33%226K

Current liabilities

6.02%7.33M

20.85%10.02M

13.32%9.29M

0.06%8.75M

-17.83%6.91M

-1.73%8.29M

-0.11%8.2M

-12.33%8.75M

Non current liabilities

Non current deferred liabilities

-6.21%3.41M

-6.12%3.47M

-6.02%3.53M

-5.93%3.58M

-5.85%3.64M

-5.79%3.7M

0.05%3.75M

-1.42%3.81M

Derivative product liabilities

443.75%957K

184.07%321K

83.33%176K

-59.37%232K

-70.81%176K

-35.80%113K

-69.91%96K

27.46%571K

Total non current liabilities

14.55%4.37M

-0.47%3.79M

-3.79%3.7M

-12.90%3.82M

-14.62%3.82M

-7.08%3.81M

-5.43%3.85M

1.58%4.38M

Total liabilities

9.05%11.7M

14.14%13.81M

7.85%12.99M

-4.27%12.57M

-16.71%10.73M

-3.48%12.1M

-1.87%12.05M

-8.13%13.13M

Shareholders'equity

Share capital

41.40%2.37M

67.18%1.86M

2,150.00%1.85M

2,803.33%1.74M

2,737.29%1.67M

1,850.88%1.11M

43.86%82K

-92.95%60K

-common stock

41.40%2.37M

67.18%1.86M

2,150.00%1.85M

2,803.33%1.74M

2,737.29%1.67M

1,850.88%1.11M

43.86%82K

-92.95%60K

-Preferred stock

----

--0

Retained earnings

-6.07%-433.27M

-6.24%-428.56M

-6.15%-422.13M

-5.81%-415.89M

-4.88%-408.49M

-5.63%-403.4M

-5.69%-397.65M

-5.97%-393.06M

Paid-in capital

9.31%468.06M

4.59%432.86M

10.46%432.5M

10.64%429.79M

10.38%428.19M

6.88%413.88M

1.16%391.56M

0.65%388.47M

Gains losses not affecting retained earnings

91.67%-2K

177.78%14K

92.59%-2K

-21.43%-17K

-33.33%-24K

-50.00%-18K

-285.71%-27K

-180.00%-14K

Total stockholders'equity

74.04%37.15M

-46.65%6.18M

302.20%12.22M

443.88%15.63M

1,489.84%21.35M

114.85%11.57M

-155.63%-6.04M

-128.56%-4.55M

Noncontrolling interests

----

--0

Total equity

74.04%37.15M

-46.65%6.18M

302.20%12.22M

443.88%15.63M

1,489.84%21.35M

114.85%11.57M

-155.63%-6.04M

-128.56%-4.55M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019	(Q2)Jun 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments	54.68%48.01M	-16.29%19.03M	-16.29%19.03M	401.93%24.2M	362.90%27.23M	198.54%31.04M	33.92%22.73M	33.92%22.73M	-78.46%4.82M	-80.09%5.88M
-Cash and cash equivalents	54.68%48.01M	-16.29%19.03M	-16.29%19.03M	401.93%24.2M	362.90%27.23M	198.54%31.04M	33.92%22.73M	33.92%22.73M	-78.46%4.82M	-80.09%5.88M
Receivables	-15.56%38K	-62.24%37K	-62.24%37K	100.00%46K	-97.61%41K	28.57%45K	180.00%98K	180.00%98K	-4.17%23K	2,280.56%1.71M
-Accounts receivable	-15.56%38K	-62.24%37K	-62.24%37K	100.00%46K	--41K	28.57%45K	180.00%98K	180.00%98K	-4.17%23K	----
-Related party accounts receivable	----	----	----	----	----	----	----	----	----	--1.68M
-Other receivables	----	----	----	----	----	----	----	----	----	--35K
Prepaid assets	-31.24%394K	6.27%542K	6.27%542K	-35.48%560K	-45.01%408K	-12.79%573K	-26.30%510K	-26.30%510K	46.37%868K	60.61%742K
Other current assets	-4.05%213K	28.57%180K	28.57%180K	121.35%197K	242.86%312K	117.65%222K	105.88%140K	105.88%140K	-13.59%89K	9.64%91K
Total current assets	52.62%48.65M	-15.72%19.78M	-15.72%19.78M	330.98%25M	232.06%27.99M	184.86%31.88M	32.14%23.47M	32.14%23.47M	-74.89%5.8M	-72.05%8.43M
Non current assets
Net PPE	4.26%49K	4.00%52K	4.00%52K	3.70%56K	5,900.00%60K	4,600.00%47K	455.56%50K	455.56%50K	170.00%54K	-97.06%1K
-Gross PPE	-96.93%70K	-96.93%70K	-96.93%70K	0.61%2.3M	3.14%2.3M	2.47%2.28M	2.47%2.28M	2.47%2.28M	2.51%2.28M	0.00%2.23M
-Accumulated depreciation	99.06%-21K	99.19%-18K	99.19%-18K	-0.54%-2.24M	-0.49%-2.24M	-0.40%-2.24M	-0.63%-2.23M	-0.63%-2.23M	-1.00%-2.23M	-1.50%-2.23M
Related parties assets	----	----	----	----	----	----	----	----	----	--1.68M
Other non current assets	0.00%150K	0.00%150K	0.00%150K	0.00%150K	0.00%150K	0.00%150K	0.67%150K	0.67%150K	1,150.00%150K	1,150.00%150K
Total non current assets	1.02%199K	1.00%202K	1.00%202K	0.98%206K	39.07%210K	30.46%197K	26.58%200K	26.58%200K	537.50%204K	228.26%151K
Total assets	52.31%48.85M	-15.58%19.99M	-15.58%19.99M	319.77%25.21M	228.66%28.2M	182.81%32.07M	32.09%23.67M	32.09%23.67M	-74.04%6.01M	-71.59%8.58M
Liabilities
Current liabilities
Payables	-4.66%3.99M	13.16%4.83M	13.16%4.83M	26.55%5.73M	8.38%5.15M	-3.48%4.18M	5.74%4.27M	5.74%4.27M	6.10%4.52M	-20.15%4.75M
-accounts payable	-4.66%3.99M	13.16%4.83M	13.16%4.83M	26.55%5.73M	8.38%5.15M	-3.48%4.18M	5.74%4.27M	5.74%4.27M	6.10%4.52M	-20.15%4.75M
Current accrued expenses	2.23%2.02M	20.59%2.72M	20.59%2.72M	-8.61%2.11M	6.19%2.4M	-9.82%1.98M	-10.04%2.26M	-10.04%2.26M	0.78%2.31M	-0.57%2.26M
Current deferred liabilities	0.00%226K	0.00%226K	0.00%226K	0.00%226K	0.00%226K	0.00%226K	0.00%226K	0.00%226K	-50.33%226K	-50.33%226K
Current liabilities	6.02%7.33M	20.85%10.02M	20.85%10.02M	13.32%9.29M	0.06%8.75M	-17.83%6.91M	-1.73%8.29M	-1.73%8.29M	-0.11%8.2M	-12.33%8.75M
Non current liabilities
Non current deferred liabilities	-6.21%3.41M	-6.12%3.47M	-6.12%3.47M	-6.02%3.53M	-5.93%3.58M	-5.85%3.64M	-5.79%3.7M	-5.79%3.7M	0.05%3.75M	-1.42%3.81M
Derivative product liabilities	443.75%957K	184.07%321K	184.07%321K	83.33%176K	-59.37%232K	-70.81%176K	-35.80%113K	-35.80%113K	-69.91%96K	27.46%571K
Total non current liabilities	14.55%4.37M	-0.47%3.79M	-0.47%3.79M	-3.79%3.7M	-12.90%3.82M	-14.62%3.82M	-7.08%3.81M	-7.08%3.81M	-5.43%3.85M	1.58%4.38M
Total liabilities	9.05%11.7M	14.14%13.81M	14.14%13.81M	7.85%12.99M	-4.27%12.57M	-16.71%10.73M	-3.48%12.1M	-3.48%12.1M	-1.87%12.05M	-8.13%13.13M
Shareholders'equity
Share capital	41.40%2.37M	67.18%1.86M	67.18%1.86M	2,150.00%1.85M	2,803.33%1.74M	2,737.29%1.67M	1,850.88%1.11M	1,850.88%1.11M	43.86%82K	-92.95%60K
-common stock	41.40%2.37M	67.18%1.86M	67.18%1.86M	2,150.00%1.85M	2,803.33%1.74M	2,737.29%1.67M	1,850.88%1.11M	1,850.88%1.11M	43.86%82K	-92.95%60K
-Preferred stock	----	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-6.07%-433.27M	-6.24%-428.56M	-6.24%-428.56M	-6.15%-422.13M	-5.81%-415.89M	-4.88%-408.49M	-5.63%-403.4M	-5.63%-403.4M	-5.69%-397.65M	-5.97%-393.06M
Paid-in capital	9.31%468.06M	4.59%432.86M	4.59%432.86M	10.46%432.5M	10.64%429.79M	10.38%428.19M	6.88%413.88M	6.88%413.88M	1.16%391.56M	0.65%388.47M
Gains losses not affecting retained earnings	91.67%-2K	177.78%14K	177.78%14K	92.59%-2K	-21.43%-17K	-33.33%-24K	-50.00%-18K	-50.00%-18K	-285.71%-27K	-180.00%-14K
Total stockholders'equity	74.04%37.15M	-46.65%6.18M	-46.65%6.18M	302.20%12.22M	443.88%15.63M	1,489.84%21.35M	114.85%11.57M	114.85%11.57M	-155.63%-6.04M	-128.56%-4.55M
Noncontrolling interests	----	----	----	----	----	----	----	----	--0	--0
Total equity	74.04%37.15M	-46.65%6.18M	-46.65%6.18M	302.20%12.22M	443.88%15.63M	1,489.84%21.35M	114.85%11.57M	114.85%11.57M	-155.63%-6.04M	-128.56%-4.55M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall